+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Newborn Screening Market Outlook 2026-2034: Market Size, Share and Growth Forecast, Industry Trends, Demand Drivers, Competitive Landscape, Pricing and Supply Chain, Customer Landscape, Opportunities and Challenges, Regional Outlook

  • PDF Icon

    Report

  • 160 Pages
  • November 2026
  • Region: Global
  • OG Analysis
  • ID: 6268754
UP TO OFF until Jan 01st 2027
The Newborn Screening Market is estimated at USD 1.14 billion in 2026 and is projected to reach USD 1.87 billion by 2034, growing at a CAGR of 6.3% during 2026-2034.

Market Overview

Newborn screening uses laboratory tests and selected physiological screening methods to identify treatable conditions early in life. Early identification of actionable conditions supports newborn screening programs. Mass spectrometry and molecular testing complement established assays.

Panel policies, follow-up capacity and false positives complicate implementation. Reliable laboratory workflows can improve screening coverage. National and subnational programs differ across North America, Europe and Asia-Pacific. Customers compare method capability, sample handling and continuing support. Initial instruments and recurring reagents or consumables can follow different purchasing cycles. Research and routine testing involve different qualification requirements. Laboratories need products that suit their samples and clearly defined analytical objectives. Qualification requires relevant analytical evidence and consistent quality. Clearly documented intended uses and limitations support informed product comparison. Purchasing evaluates supply continuity alongside specifications. Reliable consumables, suitable training and effective service help laboratories maintain their planned workloads.

Key Takeaways

  • Demand drivers: Early identification of actionable conditions supports newborn screening programs. A larger research field does not automatically create demand for every instrument or assay. Quality records and controlled changes support repeatable work over time.
  • Technology and performance: Mass spectrometry and molecular testing complement established assays. Calibration, controls and workflow integration influence the quality of usable results. Customers also need clearly defined responsibilities for method setup and continuing service.
  • Challenges and economics: Panel policies, follow-up capacity and false positives complicate implementation. Maintenance, repeat measurements and required controls influence the economics of routine analytical work. Application-specific support distinguishes a product that is technically available from a reliable workflow under actual laboratory conditions.
  • Commercial opportunities: Reliable laboratory workflows can improve screening coverage. Application expertise can help customers establish useful workflows. Dependable methods, documentation and continuing support encourage repeat purchasing. Commercial demand follows the analytical tasks performed, the sample workload and the resources available to sustain reliable laboratory operations.
  • Geographic considerations: National and subnational programs differ across North America, Europe and Asia-Pacific. Research funding and laboratory infrastructure differ between countries. Local technical support and supply access affect practical regional opportunities.
  • Application requirements: Newborn screening uses laboratory tests and selected physiological screening methods to identify treatable conditions early in life. Research and routine testing involve different qualification requirements. Laboratories need products that suit their samples and clearly defined analytical objectives.
  • Quality and qualification: Qualification requires relevant analytical evidence and consistent quality. Clearly documented intended uses and limitations support informed product comparison. Mass spectrometry and molecular testing complement established assays. Customers compare method capability, sample handling and continuing support.
  • Purchasing and delivery: Programs assess validated assays, turnaround and confirmatory-care arrangements. Purchasing evaluates supply continuity alongside specifications. Reliable consumables, suitable training and effective service help laboratories maintain their planned workloads.
  • Competitive positioning: Revvity, Thermo Fisher Scientific and Agilent Technologies are among the companies covered. The analysis distinguishes relevant product, technology and channel roles, with emphasis on application fit, supply capabilities and customer support.
  • Outlook priorities: The newborn screening outlook depends on the interaction of end-use demand, product qualification and commercially viable delivery. Reliable laboratory workflows can improve screening coverage. National and subnational programs differ across North America, Europe and Asia-Pacific.

Competitive Landscape

The newborn screening competitive landscape includes Revvity, Thermo Fisher Scientific, Agilent Technologies and Bio-Rad Laboratories, alongside the other companies named in this report. Customers compare method capability, sample handling and continuing support. Initial instruments and recurring reagents or consumables can follow different purchasing cycles. Qualification requires relevant analytical evidence and consistent quality. Clearly documented intended uses and limitations support informed product comparison. Purchasing evaluates supply continuity alongside specifications. Reliable consumables, suitable training and effective service help laboratories maintain their planned workloads. The study compares relevant portfolios and routes to market, separating direct product provision from technology, distribution and service roles where applicable. Strategic assessment focuses on product development, application support and market access without treating every participant as a supplier of identical offerings.

Companies Mentioned

  • Revvity
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Danaher
  • Merck KGaA
  • QIAGEN
  • Waters Corporation
  • Masimo
  • Natus Medical
  • Chromsystems
  • Labsystems Diagnostics
  • Baebies
  • Trivitron Healthcare
  • AutoGenomics
  • Siemens Healthineers
  • Abbott
  • Roche
  • Fujifilm

Newborn Screening Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Newborn Screening Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analysed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across the report’s covered markets.

Countries Covered

  • North America - Newborn Screening Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Newborn Screening Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • BeNeLux
    • Russia
    • Sweden

  • Asia-Pacific - Newborn Screening Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Newborn Screening Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Newborn Screening Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru
* We can include data and analysis of additional countries on demand.

Research Methodology

This study combines primary inputs from industry experts across the Newborn Screening value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

  • What are the current market size and outlook across the covered markets?
  • Which product and customer categories offer the most relevant opportunities?
  • How do supply conditions, pricing and competitive strategies affect market development?
  • Which risks and practical investment considerations should decision makers evaluate?

Your Key Takeaways from the Newborn Screening Market Report

  • Global Newborn Screening Market size and growth projections (CAGR), 2026-2034
  • Impact of geopolitical developments on Newborn Screening trade, costs, and supply chains
  • Newborn Screening Market size, share, and outlook across the 5 regions and country/subregional markets listed above, 2026-2034
  • Newborn Screening Market size, CAGR, and market share of key products, applications, and end-user verticals, 2026-2034
  • Short- and long-term Newborn Screening Market trends, drivers, restraints, and opportunities
  • Porter’s Five Forces analysis, technological developments, and Newborn Screening supply chain analysis
  • Newborn Screening trade analysis, Newborn Screening Market price analysis, and Newborn Screening supply/demand dynamics
  • Company profiles covering business overview, key strategies, financial information where available, and relevant products
  • Latest Newborn Screening Market news and developments

This product will be delivered within 1-3 business days.

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Global Newborn Screening Market Summary, 2026
2.1 Newborn Screening Industry Overview
2.1.1 Global Newborn Screening Market Revenues (In US$ billion)
2.2 Newborn Screening Market Scope
2.3 Research Methodology
3. Newborn Screening Market Insights, 2025-2035
3.1 Newborn Screening Market Drivers
3.2 Newborn Screening Market Restraints
3.3 Newborn Screening Market Opportunities
3.4 Newborn Screening Market Challenges
3.5 Tariff Impact on Global Newborn Screening Supply Chain Patterns
4. Newborn Screening Market Analytics
4.1 Newborn Screening Market Size and Share, Key Product, 2026 Vs 2035
4.2 Newborn Screening Market Size and Share, Dominant Application, 2026 Vs 2035
4.3 Newborn Screening Market Size and Share, Leading Sales Channel, 2026 Vs 2035
4.4 Newborn Screening Market Size and Share, High Growth Countries, 2026 Vs 2035
4.5 Five Forces Analysis for Global Newborn Screening Market
4.5.1 Newborn Screening Industry Attractiveness Index, 2026
4.5.2 Newborn Screening Supplier Intelligence
4.5.3 Newborn Screening Buyer Intelligence
4.5.4 Newborn Screening Competition Intelligence
4.5.5 Newborn Screening Product Alternatives and Substitutes Intelligence
4.5.6 Newborn Screening Market Entry Intelligence
5. Global Newborn Screening Market Statistics - Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2035
5.1 World Newborn Screening Market Size, Potential and Growth Outlook, 2025-2035
5.1 Global Newborn Screening Sales Outlook and CAGR Growth By Product, 2025-2035
5.2 Global Newborn Screening Sales Outlook and CAGR Growth By Application, 2025-2035
5.3 Global Newborn Screening Sales Outlook and CAGR Growth By Sales Channel, 2025-2035
5.4 Global Newborn Screening Market Sales Outlook and Growth by Region, 2025-2035
6. Asia-Pacific Newborn Screening Industry Statistics - Market Size, Share, Competition and Outlook
6.1 Asia-Pacific Newborn Screening Market Insights, 2026
6.2 Asia-Pacific Newborn Screening Market Revenue Forecast By Product, 2025-2035
6.3 Asia-Pacific Newborn Screening Market Revenue Forecast By Application, 2025-2035
6.4 Asia-Pacific Newborn Screening Market Revenue Forecast By Sales Channel, 2025-2035
6.5 Asia-Pacific Newborn Screening Market Revenue Forecast by Country, 2025-2035
6.5.1 China Newborn Screening Market Size, Opportunities, Growth 2025-2035
6.5.2 India Newborn Screening Market Size, Opportunities, Growth 2025-2035
6.5.3 Japan Newborn Screening Market Size, Opportunities, Growth 2025-2035
6.5.4 Australia Newborn Screening Market Size, Opportunities, Growth 2025-2035
7. Europe Newborn Screening Market Data, Penetration, and Business Prospects to 2035
7.1 Europe Newborn Screening Market Key Findings, 2026
7.2 Europe Newborn Screening Market Size and Percentage Breakdown By Product, 2025-2035
7.3 Europe Newborn Screening Market Size and Percentage Breakdown By Application, 2025-2035
7.4 Europe Newborn Screening Market Size and Percentage Breakdown By Sales Channel, 2025-2035
7.5 Europe Newborn Screening Market Size and Percentage Breakdown by Country, 2025-2035
7.5.1 Germany Newborn Screening Market Size, Trends, Growth Outlook to 2035
7.5.2 United Kingdom Newborn Screening Market Size, Trends, Growth Outlook to 2035
7.5.2 France Newborn Screening Market Size, Trends, Growth Outlook to 2035
7.5.2 Italy Newborn Screening Market Size, Trends, Growth Outlook to 2035
7.5.2 Spain Newborn Screening Market Size, Trends, Growth Outlook to 2035
8. North America Newborn Screening Market Size, Growth Trends, and Future Prospects to 2035
8.1 North America Snapshot, 2026
8.2 North America Newborn Screening Market Analysis and Outlook By Product, 2025-2035
8.3 North America Newborn Screening Market Analysis and Outlook By Application, 2025-2035
8.4 North America Newborn Screening Market Analysis and Outlook By Sales Channel, 2025-2035
8.5 North America Newborn Screening Market Analysis and Outlook by Country, 2025-2035
8.5.1 United States Newborn Screening Market Size, Share, Growth Trends and Forecast, 2025-2035
8.5.1 Canada Newborn Screening Market Size, Share, Growth Trends and Forecast, 2025-2035
8.5.1 Mexico Newborn Screening Market Size, Share, Growth Trends and Forecast, 2025-2035
9. South and Central America Newborn Screening Market Drivers, Challenges, and Future Prospects
9.1 Latin America Newborn Screening Market Data, 2026
9.2 Latin America Newborn Screening Market Future By Product, 2025-2035
9.3 Latin America Newborn Screening Market Future By Application, 2025-2035
9.4 Latin America Newborn Screening Market Future By Sales Channel, 2025-2035
9.5 Latin America Newborn Screening Market Future by Country, 2025-2035
9.5.1 Brazil Newborn Screening Market Size, Share and Opportunities to 2035
9.5.2 Argentina Newborn Screening Market Size, Share and Opportunities to 2035
10. Middle East Africa Newborn Screening Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2026
10.2 Middle East Africa Newborn Screening Market Statistics By Product, 2025-2035
10.3 Middle East Africa Newborn Screening Market Statistics By Application, 2025-2035
10.4 Middle East Africa Newborn Screening Market Statistics By Sales Channel, 2025-2035
10.5 Middle East Africa Newborn Screening Market Statistics by Country, 2025-2035
10.5.1 Middle East Newborn Screening Market Value, Trends, Growth Forecasts to 2035
10.5.2 Africa Newborn Screening Market Value, Trends, Growth Forecasts to 2035
11. Newborn Screening Market Structure and Competitive Landscape
11.1 Key Companies in Newborn Screening Industry
11.2 Newborn Screening Business Overview
11.3 Newborn Screening Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis
12. Appendix
12.1 Global Newborn Screening Market Volume (Tons)
12.1 Global Newborn Screening Trade and Price Analysis
12.2 Newborn Screening Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Newborn Screening Industry Report Sources and Methodology

Companies Mentioned

  • Revvity
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Danaher
  • Merck KGaA
  • QIAGEN
  • Waters Corporation
  • Masimo
  • Natus Medical
  • Chromsystems
  • Labsystems Diagnostics
  • Baebies
  • Trivitron Healthcare
  • AutoGenomics
  • Siemens Healthineers
  • Abbott
  • Roche
  • Fujifilm

Table Information